Education
About Us
Working with TipRanks
Follow Us
Mersana Therapeutics Inc (MRSN)
NASDAQ:MRSN
Earnings Data
Report Date
Mar 04, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-3.05Last Year’s EPS
-2.75Same Quarter Last Year
Based on 4 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The call highlighted significant progress in clinical trials and milestone achievements, especially in the Emi-Le and XMT-2056 programs. However, challenges remain with proteinuria management and modest revenue growth, balanced by a stable financial outlook.Company Guidance
Emi-Le Clinical Progress
Strong enrollment progress in Emi-Le expansion cohorts with over 45 patients enrolled. The confirmed objective response rate in adenoid cystic carcinoma was 56%, showcasing potential in rare cancers.
ASCO and ESMO Presentations
Oral presentations at ASCO 2025 and ESMO Breast Cancer 2025 highlighted clinical activity in B7-H4 expressing tumors and potential in triple-negative breast cancer (TNBC).
XMT-2056 Milestone Achievement
Achieved a $15 million development milestone with GSK for XMT-2056, indicating progress in the HER2-expressing tumors segment.
Financial Stability and Cash Runway
Ended Q2 2025 with $77 million in cash and expect to support operating plan commitments into mid-2026 without assuming future milestone payments.
MRSN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
MRSN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 14, 2025 | $27.43 | $27.92 | +1.79% |
Aug 13, 2025 | $6.07 | $6.81 | +12.19% |
May 15, 2025 | $9.50 | $7.86 | -17.26% |
Mar 03, 2025 | $13.08 | $12.00 | -8.26% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Mersana Therapeutics Inc (MRSN) report earnings?
Mersana Therapeutics Inc (MRSN) is schdueled to report earning on Mar 04, 2026, TBA (Confirmed).
What is Mersana Therapeutics Inc (MRSN) earnings time?
Mersana Therapeutics Inc (MRSN) earnings time is at Mar 04, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is MRSN EPS forecast?
MRSN EPS forecast for the fiscal quarter 2025 (Q4) is -3.05.